Aquestive Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $14,446 | $13,015 | $12,807 | $10,003 |
Gross Profit | 10,977 | 7,179 | 8,301 | 5,442 |
EBITDA | -4,002 | -27,457 | -11,034 | -9,132 |
EBIT | -4,121 | -27,587 | -11,173 | -9,272 |
Net Income | -8,057 | -31,860 | -15,446 | -13,548 |
Net Change In Cash | 14,446 | 13,015 | 12,807 | 10,003 |
Free Cash Flow | -14,858 | -8,554 | -12,884 | -8,021 |
Cash | 110,734 | 121,169 | 129,062 | 60,536 |
Basic Shares | 122,609 | 121,966 | 110,584 | 99,326 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $44,545 | $57,561 | $50,583 | $47,680 |
Gross Profit | 27,390 | 39,689 | 29,752 | 28,294 |
EBITDA | -66,125 | -26,616 | 1,182 | -39,580 |
EBIT | -66,684 | -27,334 | -163 | -41,967 |
Net Income | -83,784 | -44,137 | -7,870 | -54,410 |
Net Change In Cash | 44,545 | 57,561 | 50,583 | 47,680 |
Free Cash Flow | -52,994 | -35,918 | -7,375 | -12,313 |
Cash | 121,169 | 71,546 | 23,872 | 27,273 |
Basic Shares | 121,966 | 86,726 | 61,255 | 48,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.05 |
2025-12-31 | -$0.26 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.12 |